AC Immune SA Common Stock ACIU
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-06T14:43:13.050Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-02-19
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T14:38:18.282542441Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-06T14:43:11.896162+00:00
AC Immune SA Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | 2.80 | 77.5% | 39.7% | |||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | 2.65 | 69.0% | 6.8% | |||
| 65Δ | 3.38 | 91.4% | 6.2% | |||
| 70Δ | 4.10 | 113.8% | 5.5% | |||
| 75Δ | 4.83 | 136.2% | 4.8% | |||
| 80Δ | 6.02 | 147.4% | 2.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 2.80
- IV
- 77.5%
- B/E move
- 39.7%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.65
- IV
- 69.0%
- B/E move
- 6.8%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.38
- IV
- 91.4%
- B/E move
- 6.2%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.10
- IV
- 113.8%
- B/E move
- 5.5%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.83
- IV
- 136.2%
- B/E move
- 4.8%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.02
- IV
- 147.4%
- B/E move
- 2.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 172.68% |
Biotechnology
ACOG
Alpha Cognition Inc. is a pioneering biopharmaceutical firm dedicated to revolutionizing the treatment landscape for neurodegenerative diseases, with a primary focus on…
More →ACRS
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with…
More →ADMA
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and…
More →AGEN
Description unavailable
More →AGIO
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The…
More →AKTS
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures and sells radio frequency (RF) filter products for the wireless mobile device…
More →